Drug Master Files for: vasopressin
✉ Email this page to a colleague
vasopressin Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 25736 | A | II | 1/24/2012 | BCN PEPTIDES SA | VASOPRESSIN |
| 27577 | I | II | 12/19/2013 | POLYPEPTIDE LABORATORIES SWEDEN AB | VASOPRESSIN |
| 28532 | A | II | 8/1/2014 | BACHEM AMERICAS INC | VASOPRESSIN, USP (BULK) |
| 32116 | A | II | 10/3/2017 | POLYPEPTIDE LABORATORIES SWEDEN AB | VASOPRESSIN |
| 32146 | A | II | 10/12/2017 | HEMMO PHARMACEUTICALS PVT LTD | VASOPRESSIN USP |
| 32769 | A | II | 5/5/2018 | INTERNATIONAL MEDICATION SYSTEMS LTD | VASOPRESSIN USP |
| 33119 | A | II | 8/27/2018 | AURO PEPTIDES LTD | VASOPRESSIN USP |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
